MedTrace Logo

PVP-Guided Decongestive Therapy in HF 2

NCT06495892 · Status: RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 650

Last updated 2024-12-04

No results posted yet for this study

Summary

The investigators hypothesize that a simple assessment of peripheral venous pressure (PVP) will better predict the diuretic need and long-term outcomes (all cause mortality, all cause rehospitalization, emergency department visits) compared to standard evaluation.

Conditions

Interventions

DRUG

Diuretic therapy

Diuretic therapy will be tailored according to peripheral venous pressure targets or standard approach

Sponsors & Collaborators

  • Ankara Etlik City Hospital

    collaborator OTHER_GOV

  • Akdeniz University

    collaborator OTHER

  • Bağcılar Training and Research Hospital

    collaborator UNKNOWN

  • Bakırçay University, Faculty of Medicine

    collaborator UNKNOWN

  • Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital

    collaborator OTHER

  • Eskişehir City Hospital

    collaborator UNKNOWN

  • İdil State Hospital

    collaborator UNKNOWN

  • Kafkas University Health Research and Application Hospital

    collaborator UNKNOWN

  • Kutahya Health Sciences University

    collaborator OTHER

  • Istanbul Mehmet Akif Ersoy Educational and Training Hospital

    collaborator OTHER_GOV

  • Pazarcık State Hospital

    collaborator UNKNOWN

  • Tokat Gaziosmanpaşa University, Faculty of Medicine

    collaborator UNKNOWN

  • Trakya University Faculty of Medicine

    collaborator UNKNOWN

  • Ataturk University

    collaborator OTHER

  • Başakşehir Çam & Sakura City Hospital

    lead OTHER_GOV

Principal Investigators

  • Emre K Aslanger, Prof · Basaksehir Pine and Sakura City Hospital

  • Özlem Yıldırımtürk, Prof · Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-07-01
Primary Completion
2025-07-01
Completion
2026-07-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06495892 on ClinicalTrials.gov